Real-time AI guidance enters live brain tumor surgery
1.University College London (UCL) and University College London Hospitals (UCLH) have performed the first surgery in an ongoing clinical trial using artificial intelligence to analyze live endoscopic video and highlight critical skull-base anatomy for the operating neurosurgeon in real time.
2. The first patient’s tumor was successfully removed with vision preserved, but the case establishes feasibility rather than efficacy, with the ongoing trial needed to determine whether real-time computational guidance measurably improves surgical safety or outcomes.
Artificial intelligence has spent years learning to interpret medical images captured before clinical decisions are made, but an ongoing neurosurgical trial is moving the algorithm into the operating room while the decision itself is unfolding. On August 26, 2026, University College London (UCL) reported the first patient treated with an in-house system that analyzed live surgical video in real time while a neurosurgeon removed a brain tumor. The 48-year-old patient had a tumor threatening his vision, and the operation at the National Hospital for Neurology and Neurosurgery successfully removed the tumor while preserving his sight. Rather than analyzing a preoperative scan, the system processed the live endoscopic feed and highlighted critical anatomical structures at the base of the brain as surgery progressed. That distinction matters because skull-base surgery occurs in a compact anatomical space where the pituitary gland, major vessels, optic apparatus, nerves, tumor tissue, and surgical instruments may be separated by millimeters. The system was trained using hundreds of annotated videos from previous endoscopic pituitary operations, allowing it to learn patterns of anatomy and surgical activity that would ordinarily take years of operative exposure to accumulate. Its potential functions extend beyond anatomy recognition to tracking instruments and instrument-tissue interactions, creating the possibility of an intraoperative system that understands both what structures are visible and what the surgeon is doing around them.
The first procedure occurred within a clinical trial funded by the National Institute for Health and Care Research (NIHR), an important distinction from introducing an algorithm into routine surgery on the basis of technical validation alone. A successful first operation demonstrates that real-time guidance can be integrated into the surgical workflow, but it cannot establish that the system improved the outcome or that the same result would not have occurred with conventional surgery. The ongoing trial is intended to evaluate feasibility, safety, and clinical outcomes, providing prospective evidence on whether the additional information actually helps surgeons make better decisions. Human factors will be central because poorly timed overlays, inaccurate segmentation, excessive alerts, or misplaced confidence in an algorithm could distract rather than assist an experienced surgeon. The broader significance is that surgical AI is moving beyond retrospective video review and training toward systems whose output can influence decisions while tissue is being manipulated. The ideal role is likely augmentation rather than autonomous surgery, particularly in anatomically complex procedures where additional visual information could help identify structures while the surgeon retains control of interpretation and action. The first case is therefore best understood as a proof of clinical integration, with the consequential question now being whether prospective trial data show that real-time computer vision can make difficult surgery measurably safer rather than simply more technologically sophisticated.
Image: PD
©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.
